Mitsubishi Ufj Asset Management (Uk) Ltd. Ani Pharmaceuticals Inc Transaction History

Mitsubishi Ufj Asset Management (Uk) Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$48.72 - $65.43 $292,320 - $392,580	-6,000 Reduced 60.0%	4,000 $220,000
Q3 2023 Nov 02, 2023	SELL	$50.28 - $64.61 $251,400 - $323,050	-5,000 Reduced 33.33%	10,000 $580,000
Q1 2023 May 02, 2023	SELL	$37.61 - $45.72 $300,880 - $365,760	-8,000 Reduced 34.78%	15,000 $596,000
Q1 2022 May 10, 2022	BUY	$26.91 - $47.15 $188,370 - $330,050	7,000 Added 43.75%	23,000 $646,000
Q3 2021 Oct 19, 2021	BUY	$26.48 - $35.99 $423,680 - $575,840	16,000 New	16,000 $525,000
Q4 2019 Jan 17, 2020	SELL	$55.65 - $79.83 $723,450 - $1.04 Million	-13,000 Closed	0 $0
Q2 2019 Jul 18, 2019	BUY	$67.77 - $82.2 $881,010 - $1.07 Million	13,000 New	13,000 $0

211

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $986M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Asset Management (Uk) Ltd., based on Form 13F filings with the SEC.

Stay updated on Mitsubishi Ufj Asset Management (Uk) Ltd. with notifications on news.